| 000 | 01631 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250512035408.0 | ||
| 264 | 0 | _c19880817 | |
| 008 | 198808s 0 0 eng d | ||
| 022 | _a0008-8749 | ||
| 024 | 7 |
_a10.1016/0008-8749(88)90327-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKitaura, M | |
| 245 | 0 | 0 |
_aDown-regulation of macrophage Ia mRNA expression by interferon (IFN)-alpha and IFN-beta mediated by de novo synthesized protein. _h[electronic resource] |
| 260 |
_bCellular immunology _cJul 1988 |
||
| 300 |
_a347-58 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCycloheximide _xtoxicity |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aH-2 Antigens _xmetabolism |
| 650 | 0 | 4 |
_aHistocompatibility Antigens Class II _xisolation & purification |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aInterferon Type I _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aInterferon-gamma _xantagonists & inhibitors |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aMacrophages _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C3H |
| 650 | 0 | 4 | _aProtein Biosynthesis |
| 650 | 0 | 4 |
_aProteins _xphysiology |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 700 | 1 | _aKato, T | |
| 700 | 1 | _aInaba, K | |
| 700 | 1 | _aSakata, T | |
| 700 | 1 | _aWatanabe, Y | |
| 700 | 1 | _aKawade, Y | |
| 700 | 1 | _aMuramatsu, S | |
| 773 | 0 |
_tCellular immunology _gvol. 114 _gno. 2 _gp. 347-58 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0008-8749(88)90327-9 _zAvailable from publisher's website |
| 999 |
_c3139939 _d3139939 |
||